Skip to main content

Main menu

  • HOME
  • ONLINE FIRST
  • CURRENT ISSUE
  • ALL ISSUES
  • AUTHORS & REVIEWERS
  • SUBSCRIBE
  • RESOURCES
    • About BJGP
    • Conference
    • Advertising
    • BJGP Life
    • eLetters
    • Librarian information
    • Alerts
    • Resilience
    • Video
    • Audio
    • COVID-19 Clinical Solutions
  • RCGP
    • BJGP for RCGP members
    • BJGP Open
    • RCGP eLearning
    • InnovAIT Journal
    • Jobs and careers
    • RCGP e-Portfolio

User menu

  • Subscriptions
  • Alerts
  • Log in

Search

  • Advanced search
British Journal of General Practice
  • RCGP
    • BJGP for RCGP members
    • BJGP Open
    • RCGP eLearning
    • InnovAIT Journal
    • Jobs and careers
    • RCGP e-Portfolio
  • Subscriptions
  • Alerts
  • Log in
  • Follow bjgp on Twitter
  • Visit bjgp on Facebook
  • Blog
  • Listen to BJGP podcast
Advertisement
British Journal of General Practice

Advanced Search

  • HOME
  • ONLINE FIRST
  • CURRENT ISSUE
  • ALL ISSUES
  • AUTHORS & REVIEWERS
  • SUBSCRIBE
  • RESOURCES
    • About BJGP
    • Conference
    • Advertising
    • BJGP Life
    • eLetters
    • Librarian information
    • Alerts
    • Resilience
    • Video
    • Audio
    • COVID-19 Clinical Solutions
Letters

Long-acting reversible contraception

Scott Wilkes
British Journal of General Practice 2013; 63 (614): 463. DOI: https://doi.org/10.3399/bjgp13X671560
Scott Wilkes
GP/Hon Clinical Senior Lecturer, Institute of Health and Society, Institute of Health & Society, Baddiley-Clark Building, Richardson Road, Newcastle upon Tyne, NE2 4AX. E-mail:
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: scott.wilkes@newcastle.ac.uk
  • Article
  • Info
  • eLetters
  • PDF
Loading

I would like to draw the attention of your readers to the conclusions of a paper recently published in the Journal of Family Planning and Reproductive Healthcare,1 the conclusion of which is that the levonorgestrel-releasing intrauterine system (LNG IUS; Mirena® Bayer) should be offered first-line without restriction to young and nulliparous women.

It is now 8 years since the National Institute for Health and Care Excellence (NICE) issued its guidance encouraging increased access to long-acting reversible contraception (LARC).2 LARC methods are more cost-effective than the combined oral contraceptive pill and will reduce the number of unintended pregnancies. This includes the ‘fit and forget’ use of the IUS.3 The IUD/IUS is not contraindicated in young nulliparous women of any age and this message seems not to be reaching our GP colleagues with nine out 10 GPs still advising women to use the contraceptive pill as a first-line choice for young nulliparous women.4

The overriding message is that the levonorgestrel-releasing IUS is a first-line contraceptive option for young and nulliparous women.

  • © British Journal of General Practice 2013

REFERENCES

  1. 1.↵
    1. Armitage CM,
    2. Mitchell C,
    3. Wigan C,
    4. Smith DA
    (2013) Uptake and continuation rates of the intrauterine system in a university student general practice population in the UK. J Fam Plann Reprod Health Care 39(3):186–189.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. National Institute for Health and Clinical Excellence
    (2005) Long-acting reversible contraception. CG30 (NICE, London) http://nice.org.uk/nicemedia/live/10974/29912/29912.pdf (accessed 5 Aug 2013).
  3. 3.↵
    1. Draper IB,
    2. Haque MS,
    3. McManus RJ
    (2012) Routine intrauterine device checks: are they advisable? J Fam Plann Reprod Health Care 38(1):15–18.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. Middleton AJ,
    2. Naish J,
    3. Singer N
    (2011) General practitioners’ views on the use of the levonorgestrel-releasing intrauterine system in young nulligravid women, in London. Eur J Contracep Reprod Health Care 16(4):311–318.
    OpenUrl
View Abstract
Back to top
Previous ArticleNext Article

In this issue

British Journal of General Practice: 63 (614)
British Journal of General Practice
Vol. 63, Issue 614
September 2013
  • Table of Contents
  • Index by author
Download PDF
Article Alerts
Or,
sign in or create an account with your email address
Email Article

Thank you for recommending British Journal of General Practice.

NOTE: We only request your email address so that the person to whom you are recommending the page knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Long-acting reversible contraception
(Your Name) has forwarded a page to you from British Journal of General Practice
(Your Name) thought you would like to see this page from British Journal of General Practice.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Long-acting reversible contraception
Scott Wilkes
British Journal of General Practice 2013; 63 (614): 463. DOI: 10.3399/bjgp13X671560

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Long-acting reversible contraception
Scott Wilkes
British Journal of General Practice 2013; 63 (614): 463. DOI: 10.3399/bjgp13X671560
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
  • Mendeley logo Mendeley

Jump to section

  • Top
  • Article
    • REFERENCES
  • Info
  • eLetters
  • PDF

More in this TOC Section

  • It’s time to look again at GP funding
  • Inequalities in CKD management can be overcome
  • Changes in patient experience associated with growth and collaboration in general practice
Show more Letters

Related Articles

Cited By...

Advertisement

BJGP Life

BJGP Open

 

@BJGPjournal's Likes on Twitter

 
 

British Journal of General Practice

NAVIGATE

  • Home
  • Current Issue
  • All Issues
  • Online First
  • Authors & reviewers

RCGP

  • BJGP for RCGP members
  • BJGP Open
  • RCGP eLearning
  • InnovAiT Journal
  • Jobs and careers
  • RCGP e-Portfolio

MY ACCOUNT

  • RCGP members' login
  • Subscriber login
  • Activate subscription
  • Terms and conditions

NEWS AND UPDATES

  • About BJGP
  • Alerts
  • RSS feeds
  • Facebook
  • Twitter

AUTHORS & REVIEWERS

  • Submit an article
  • Writing for BJGP: research
  • Writing for BJGP: other sections
  • BJGP editorial process & policies
  • BJGP ethical guidelines
  • Peer review for BJGP

CUSTOMER SERVICES

  • Advertising
  • Contact subscription agent
  • Copyright
  • Librarian information

CONTRIBUTE

  • BJGP Life
  • eLetters
  • Feedback

CONTACT US

BJGP Journal Office
RCGP
30 Euston Square
London NW1 2FB
Tel: +44 (0)20 3188 7679
Email: journal@rcgp.org.uk

British Journal of General Practice is an editorially-independent publication of the Royal College of General Practitioners
© 2021 British Journal of General Practice

Print ISSN: 0960-1643
Online ISSN: 1478-5242